Quality-of-Life Outcomes Following Endoscopic Resection of Sinonasal Inverted Papilloma.
Schneiderian cell papilloma
endoscopic surgery
inverted papilloma
quality of life
Journal
The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378
Informations de publication
Date de publication:
24 Aug 2024
24 Aug 2024
Historique:
revised:
22
07
2024
received:
25
05
2024
accepted:
31
07
2024
medline:
24
8
2024
pubmed:
24
8
2024
entrez:
24
8
2024
Statut:
aheadofprint
Résumé
There is growing interest in assessing patient quality of life (QOL) following treatment of sinonasal tumors, including inverted papilloma (IP). We aimed to elucidate the natural history of postoperative QOL outcomes in IP patients treated with surgery. Cases of sinonasal IP treated surgically at 4 tertiary academic rhinology centers were retrospectively reviewed. SNOT-22 scores were used to evaluate QOL preoperatively and postoperatively (1, 3, 6, 12 months). Repeated-measures ANOVA assessed for differences in mean scores over time. Linear regression identified factors associated with QOL longitudinally. 373 patients were analyzed. Mean preoperative SNOT-22 score was 20.6 ± 20.4, which decreased to 16.3 ± 18.8 (p = 0.041) and 11.8 ± 15.0 (p < 0.001) at 1 and 3 months postoperatively, respectively. No further changes in SNOT-22 scores occurred beyond 3 months postoperatively (p > 0.05). When analyzed by SNOT-22 subdomains, nasal, sleep, and otologic/facial subdomain scores (all p < 0.05) demonstrated improvement at 12-month follow-up compared with preoperative scores; this was not observed for the emotional subdomain score (p = 0.800). Recurrent cases were associated with higher long-term SNOT-22 scores (β = 7.08; p = 0.017). Age, sex, degree of dysplasia, prior surgery, primary site, and smoking history did not correlate with symptoms (all p > 0.05). QOL outcomes related to IP resection are largely driven by nasal, sleep, and otologic/facial subdomains, though patients appear to experience enduring improvement as early as 3 months postoperatively. Recurrent disease is a major driver of negative QOL. 4 Laryngoscope, 2024.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIGMS NIH HHS
ID : T32GM008620
Pays : United States
Informations de copyright
© 2024 The Author(s). The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc.
Références
Peng P, Har‐El G. Management of inverted papillomas of the nose and paranasal sinuses. Am J Otolaryngol. 2006;27(4):233‐237. https://doi.org/10.1016/j.amjoto.2005.11.005
von Buchwald C, Bradley PJ. Risks of malignancy in inverted papilloma of the nose and paranasal sinuses. Curr Opin Otolaryngol Head Neck Surg. 2007;15(2):95‐98. https://doi.org/10.1097/MOO.0b013e3280803d9b
Segal K, Atar E, Mor C, Har‐El G, Sidi J. Inverting papilloma of the nose and paranasal sinuses. Laryngoscope. 1986;96(4):394‐398. https://doi.org/10.1288/00005537-198604000-00011
Reh DD, Lane AP. The role of endoscopic sinus surgery in the management of sinonasal inverted papilloma. Curr Opin Otolaryngol Head Neck Surg. 2009;17(1):6‐10. https://doi.org/10.1097/MOO.0b013e32831b9cd1
Wu V, Siu J, Yip J, Lee JM. Endoscopic management of maxillary sinus inverted papilloma attachment sites to minimize disease recurrence. J Otolaryngol—Head Neck Surg. 2018;47:24. https://doi.org/10.1186/s40463-018-0271-1
Trent MS, Goshtasbi K, Hui L, et al. A systematic review of definitive treatment for inverted papilloma attachment site and associations with recurrence. Otolaryngol Neck Surg. 2022;167(3):425‐433. https://doi.org/10.1177/01945998211051975
Gupta R, Rady PL, Sikora AG, Tyring SK. The role of human papillomavirus in the pathogenesis of sinonasal inverted papilloma: a narrative review. Rev Med Virol. 2021;31(3):e2178. https://doi.org/10.1002/rmv.2178
Yu S, Grose E, Lee DJ, Wu V, Pellarin M, Lee JM. Evaluation of inverted papilloma recurrence rates and factors associated recurrence after endoscopic surgical resection: a retrospective review. J Otolaryngol—Head Neck Surg. 2023;52(1):34. https://doi.org/10.1186/s40463-023-00638-5
Deckard NA, Harrow BR, Barnett SL, Batra PS. Comparative analysis of quality‐of‐life metrics after endoscopic surgery for Sinonasal neoplasms. Am J Rhinol Allergy. 2015;29(2):151‐155. https://doi.org/10.2500/ajra.2015.29.4137
Derousseau T, Manjunath L, Harrow B, Zhang S, Batra PS. Long‐term changes in quality of life after endoscopic resection of sinonasal and skull‐base tumors. Int Forum Allergy Rhinol. 2015;5(12):1129‐1135. https://doi.org/10.1002/alr.21608
van Samkar A, Georgalas C. Long‐term quality of life after endoscopic removal of sinonasal inverted papillomas: a 6‐year cohort analysis in a tertiary academic hospital. Eur Arch Otorhinolaryngol. 2016;273(6):1433‐1437. https://doi.org/10.1007/s00405-015-3751-1
Hoehle LP, Phillips KM, Caradonna DS, Gray ST, Sedaghat AR. A contemporary analysis of clinical and demographic factors of chronic rhinosinusitis patients and their association with disease severity. Ir J Med Sci. 2018;187(1):215‐221. https://doi.org/10.1007/s11845-017-1639-3
Feng AL, Wesely NC, Hoehle LP, et al. A validated model for the 22‐item Sino‐nasal outcome test subdomain structure in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2017;7(12):1140‐1148. https://doi.org/10.1002/alr.22025
Lee S, Lee DK. What is the proper way to apply the multiple comparison test? Korean J Anesthesiol. 2018;71(5):353‐360. https://doi.org/10.4097/kja.d.18.00242
Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22‐item Sinonasal outcome test. Clin Otolaryngol. 2009;34(5):447‐454. https://doi.org/10.1111/j.1749-4486.2009.01995.x
Viitasalo S, Sintonen H, Lilja M, Hytonen M, Aaltonen LM. Quality of life after operative treatment of sinonasal inverted papilloma—a prospective study. Rhinology. 2023;61(1):71‐76. https://doi.org/10.4193/Rhin22.255
McCoul ED, Anand VK, Bedrosian JC, Schwartz TH. Endoscopic skull base surgery and its impact on sinonasal‐related quality of life. Int Forum Allergy Rhinol. 2012;2(2):174‐181. https://doi.org/10.1002/alr.21008
Bugten V, Nordgård S, Steinsvåg S. The effects of debridement after endoscopic sinus surgery. Laryngoscope. 2006;116(11):2037‐2043. https://doi.org/10.1097/01.mlg.0000241362.06072.83
Bernstein JM, Lebowitz RA, Jacobs JB. Initial report on postoperative healing after endoscopic sinus surgery with the microdebrider. Otolaryngol—Head Neck Surg off J Am Acad Otolaryngol‐Head Neck Surg. 1998;118(6):800‐803. https://doi.org/10.1016/S0194-5998(98)70272-4
Tong CCL, Patel NN, Maina IW, et al. Inverted papilloma with multifocal attachment is associated with increased recurrence. Int Forum Allergy Rhinol. 2019;9(8):865‐869. https://doi.org/10.1002/alr.22342
Bugter O, Monserez DA, van Zijl FVWJ, Baatenburg de Jong RJ, Hardillo JA. Surgical management of inverted papilloma; a single‐center analysis of 247 patients with long follow‐up. J Otolaryngol—Head Neck Surg. 2017;46:67. https://doi.org/10.1186/s40463-017-0246-7
Ayoub N, Walgama E, Thamboo A, et al. Correlation between extent of sinus surgery, radiographic disease, and postoperative outcomes. Rhinology. 2020;58(1):36‐44. https://doi.org/10.4193/Rhin19.213
Harvey RJ, Sheehan PO, Debnath NI, Schlosser RJ. Transseptal approach for extended endoscopic resections of the maxilla and infratemporal fossa. Am J Rhinol Allergy. 2009;23(4):426‐432. https://doi.org/10.2500/ajra.2009.23.3333
Ramakrishnan VR, Suh JD, Chiu AG, Palmer JN. Septal dislocation for endoscopic access of the anterolateral maxillary sinus and infratemporal fossa. Am J Rhinol Allergy. 2011;25(2):128‐130. https://doi.org/10.2500/ajra.2011.25.3559
Lee JT, Suh JD, Carrau RL, Chu MW, Chiu AG. Endoscopic Denker's approach for resection of lesions involving the anteroinferior maxillary sinus and infratemporal fossa. Laryngoscope. 2017;127(3):556‐560. https://doi.org/10.1002/lary.26237
McCormick JP, Suh JD, Wang EW, et al. Modified endoscopic Denker's approach for Management of Anterior Maxillary Sinus Tumors: multicenter series of 58 cases. Am J Rhinol Allergy. 2022;36(6):763‐772. https://doi.org/10.1177/19458924221110652
Zhou B, Han DM, Cui SJ, Huang Q, Wang CS. Intranasal endoscopic prelacrimal recess approach to maxillary sinus. Chin Med J (Engl). 2013;126(7):1276. https://doi.org/10.3760/cma.j.issn.0366-6999.20121754
Li L, London Nyall R, Prevedello DM, Carrau RL. Endoscopic endonasal approach to the pterygopalatine fossa and infratemporal fossa: comparison of the Prelacrimal and Denker's corridors. Am J Rhinol Allergy. 2022;36(5):599‐606. https://doi.org/10.1177/19458924221097159
Zhou B, Huang Q, Sun J, et al. Resection of inverted papilloma of the maxillary sinus via a Prelacrimal recess approach: a multicenter retrospective analysis of surgical efficacy. Am J Rhinol Allergy. 2018;32(6):518‐525. https://doi.org/10.1177/1945892418801243
Suzuki M, Nakamura Y, Yokota M, Ozaki S, Murakami S. Modified transnasal endoscopic medial maxillectomy through prelacrimal duct approach. Laryngoscope. 2017;127(10):2205‐2209. https://doi.org/10.1002/lary.26529
Mohankumar V, Kannan DS, Narendrakumar V, Kuppuswamy S, Baby AN. A comparative study between endoscopic Prelacrimal approach and middle meatal antrostomy for maxillary sinus pathologies. Indian J Otolaryngol Head Neck Surg. 2022;74(1):90‐95. https://doi.org/10.1007/s12070-021-02703-9
Lin YH, Chen WC. Clinical outcome of endonasal endoscopic prelacrimal approach in managing different maxillary pathologies. PeerJ. 2020;8:e8331. https://doi.org/10.7717/peerj.8331
Kuan EC, Wang EW, Adappa ND, et al. International consensus statement on allergy and rhinology: Sinonasal tumors. Int Forum Allergy Rhinol. 2024;14(2):149‐608. https://doi.org/10.1002/alr.23262
Chow VJ, Tsetsos N, Poutoglidis A, Georgalas C. Quality of life in sinonasal tumors: an up‐to‐date review. Curr Opin Otolaryngol Head Neck Surg. 2022;30(1):46‐57. https://doi.org/10.1097/MOO.0000000000000774
Rudmik L, Soler ZM, Mace JC, DeConde AS, Schlosser RJ, Smith TL. Using preoperative SNOT‐22 score to inform patient decision for endoscopic sinus surgery. Laryngoscope. 2015;125(7):1517‐1522. https://doi.org/10.1002/lary.25108
Grimm DR, Beswick DM, Maoz SL, et al. SNOT‐22 subdomain outcomes following treatment for sinonasal malignancy: a prospective, multicenter study. Int Forum Allergy Rhinol. Published online February 19. 2024;14(8):1314‐1326. https://doi.org/10.1002/alr.23338
Fleseriu CM, Beswick DM, Maoz SL, et al. Predictive factors for decreased baseline quality of life in patients with sinonasal malignancies. Int Forum Allergy Rhinol. 2024;14(4):775‐785. https://doi.org/10.1002/alr.23261
Maoz SL, Wang EW, Hwang PH, et al. Long‐term quality of life after treatment in sinonasal malignancy: a prospective, multicenter study. Int Forum Allergy Rhinol. 2023;13(11):2030‐2042. https://doi.org/10.1002/alr.23171